- Home
- ABM vs IMVT Comparison
ABM vs IMVT Comparison
Compare ABM & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABM
- IMVT
- Stock Information
- Founded
- ABM 1909
- IMVT N/A
- Country
- ABM United States
- IMVT United States
- Employees
- ABM N/A
- IMVT N/A
- Industry
- ABM Diversified Commercial Services
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ABM Finance
- IMVT Health Care
- Exchange
- ABM Nasdaq
- IMVT Nasdaq
- Market Cap
- ABM 2.9B
- IMVT 2.5B
- IPO Year
- ABM N/A
- IMVT N/A
- Fundamental
- Price
- ABM $50.71
- IMVT $14.14
- Analyst Decision
- ABM Hold
- IMVT Buy
- Analyst Count
- ABM 3
- IMVT 10
- Target Price
- ABM $53.67
- IMVT $40.14
- AVG Volume (30 Days)
- ABM 397.1K
- IMVT 1.4M
- Earning Date
- ABM 06-05-2025
- IMVT 05-28-2025
- Dividend Yield
- ABM 2.09%
- IMVT N/A
- EPS Growth
- ABM N/A
- IMVT N/A
- EPS
- ABM 1.27
- IMVT N/A
- Revenue
- ABM $8,404,700,000.00
- IMVT N/A
- Revenue This Year
- ABM $3.06
- IMVT $108.88
- Revenue Next Year
- ABM $2.58
- IMVT N/A
- P/E Ratio
- ABM $40.11
- IMVT N/A
- Revenue Growth
- ABM 2.81
- IMVT N/A
- 52 Week Low
- ABM $40.85
- IMVT $12.72
- 52 Week High
- ABM $59.78
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- ABM 64.55
- IMVT 42.87
- Support Level
- ABM $49.08
- IMVT $13.36
- Resistance Level
- ABM $50.11
- IMVT $14.76
- Average True Range (ATR)
- ABM 1.01
- IMVT 0.89
- MACD
- ABM 0.38
- IMVT 0.05
- Stochastic Oscillator
- ABM 89.39
- IMVT 36.36
About ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).